bioRxivCancer BiologyPreprint
Caveolin-1 regulates context-dependent signaling and survival in Ewing Sarcoma.
Dagan SegaliD, Xiaoyu WangiD, Hanieh Mazloom-FarsibafiD, Felix Y. Zhou, Divya RajendraniD, Erin B. ButleriD, Bingying CheniD, Bo-Jui ChangiD, Khushi Ahuja, Averi Perny, Kushal BhattiD, Dana Kim ReediD, Diego H. CastrillóniD, Jeon LeeiD, Elise C. Jeffery, Lei Wang, Khai M. NguyeniD, Noelle Sevilir WilliamsiD, Stephen X. SkapekiD, Satwik RajaramiD, Reto Paul FiolkaiD, Khuloud JaqamaniD, Gary C. HoniD, James F. AmatrudaiD, Gaudenz M. DanuseriD
Abstract
Plasticity is a hallmark function of cancer cells, yet the mechanisms that enable dynamic switching between survival states remain incompletely understood. Here, we identify Caveolin-1, a membrane-domain scaffolding protein, as a context-dependent regulator of survival signaling in Ewing sarcoma (EwS). Single-cell analyses reveal a distinct subpopulation of EwS cells marked by high CD99 and elevated Caveolin-1 expression. These CD99High cells exhibit unique morphology, transcriptional programs, and markedly enhanced survival both under chemotherapeutic challenge and in vivo. Importantly, CD99High and CD99Low states are reversible, providing EwS cells with a flexible route to survival-oriented plasticity. Mechanistically, we show that Caveolin-1 in CD99High cells orchestrates PI3K/AKT survival signaling by modulating the spatial organization of PI3K activity on the plasma membrane. We propose that the CD99High state establishes a Caveolin-1-driven signaling architecture that supports survival through mechanisms distinct from those used by CD99Low cells. These findings uncover a dynamic state transition in EwS cells and position Caveolin-1 as a key driver of context-specific survival signaling.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances chemotherapy efficacy in Ewing sarcoma
Alina Ritter, Malenka Zimmermann, … Florencia Cidre‐Aranaz·bioRxiv·Aug 7, 2025
- Chimeric protein EWS-FLI1 drives cell proliferation in Ewing Sarcoma via overexpression of KCNN1.
M. Dupuy, M. Gueguinou, … F. Verrecchia·bioRxiv·Apr 24, 2023
- Dynamic modelling of EWS::FLI1 fluctuations reveals molecular determinants of phenotypic tumor plasticity and prognosis in Ewing sarcoma
Veveeyan Suresh, Christoph Hafemeister, … Valerie Fock·bioRxiv·Apr 3, 2025
- DDK inhibition disrupts replication leading to mitotic catastrophe in Ewing sarcoma
J. C. Martin, A. Gupta, … J. Ohm·bioRxiv·Nov 2, 2021
- Multidirectional Cellular Plasticity in Ewing Sarcoma Reveals a Tumor-CAF Continuum and Novel Immunotherapeutic Targets
Mohamed A. Sharif, Abdul Saboor Khan, … Joyce Ellen Ohm·bioRxiv·Aug 4, 2026
- Caveolae set levels of epithelial monolayer tension to eliminate tumor cells
J. L. C. Teo, G. A. Gomez, … A. S. Yap·bioRxiv·May 9, 2019